|
VRTX | Vertex Pharmaceuticals Inc / Ma |
|
|
VRTX | Vertex Pharmaceuticals Inc / Ma |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.15 |
| Leverage | 30.34% |
| Market Cap | $ 117.1B |
| PE | 31.95 |
| Dividend Yield | 0.00% |
| Profit | $ 3.7B |
| Margin | 31.43% |
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.